Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00189605 · ClinicalTrials.gov registry record · Phase 4
Prospective, Randomized, Multi-center Clinical Study of Plasma Disc Decompression
A Phase 4 study, sponsored by ArthroCare Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
NCT00189605: Completed Phase 4 study, sponsored by ArthroCare Corporation.
NCT00189605 is a Phase 4 study that has completed, run by ArthroCare Corporation. The registered enrollment target is 90 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00189605, a Phase 4 study, has completed, sponsored by ArthroCare Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
Study Summary
The goal of this post-marketing surveillance study is to compare two procedures which are used to treat patients who require a disc decompression procedure. These procedures are: 1) plasma disc decompression procedure using Coblation technology and 2) fluoroscopy guided transforaminal epidural steroid injection (TFESI). The study will evaluate treatment efficacy and rate of improvement in symptoms through the first six months following the procedure. The principal objectives of this study are to determine whether subjects receiving the plasma disc decompression procedure demonstrate: 1. Improved clinical outcomes over subjects receiving TFESI 2. More rapid reversal of symptoms than subjects receiving TFESI
Interventions
- DEVICE Perc-DLR/Perc-DLG
- DRUG Fluoroscopy guided transforaminal epidural steroid injection (TFESI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-04 |
| Phase | Phase 4 |
What the finished NCT00189605 record still lists
NCT00189605 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Perc-DLR/Perc-DLG is the first listed.
NCT00189605 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00189605 about?
NCT00189605 is a clinical study titled "Prospective, Randomized, Multi-center Clinical Study of Plasma Disc Decompression". The goal of this post-marketing surveillance study is to compare two procedures which are used to treat patients who require a disc decompression procedure. These procedures are: 1) plasma disc decompression procedure using Coblation technology and 2) fluoroscopy guided transforaminal epidural stero...
What is the current status of trial NCT00189605?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2004-09. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00189605?
The interventions under investigation include: Perc-DLR/Perc-DLG (DEVICE), Fluoroscopy guided transforaminal epidural steroid injection (TFESI) (DRUG).
Who is sponsoring clinical trial NCT00189605?
This trial is sponsored by ArthroCare Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00189605's enrollment target sits among peer trials
90 886th of 2000 higher than 1,088 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia